Harvard Apparatus Regenerative Technology, Inc.
No enriched coverage for $HRGN in the last 7 days.
No SEC Form 4 filings for $HRGN in the last 30 days.
See all $HRGN insider activity →Berkshire Hathaway bought Lennar (LEN) shares worth $136M. Insiders at Anixa (ANIX), DeFi (DFDV), Clipper (CLPR), and Harvard Apparatus (HRGN) made purchases. CrowdStrike (CRWD) CFO and Robinhood (HOOD) CEO sold shares worth $125M and $30M, respectively. Everpure (P) and Fastly (FSLY) insiders also sold shares.
He Junli (CEO) purchased 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. (HRGN) at an average of $1.07 ($1.05–$2.15, $0.39M total) across 2 trades over 2026-09-11 to 2026-09-15.
Harvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the I
Recent HRGN coverage spans corporate actions, financial news and insider activity.
Positive signal from CEO buying at a discount.
Insider purchase signals confidence but size is modest relative to market cap.
The capital raise adds cash but dilutes existing shareholders; modest impact on a micro‑cap.
The filing adds near-term financing and introduces dilution risk if the next qualifying equity raise occurs before maturity.
Routine shareholder-meeting voting outcomes; no new financial guidance, deal, or enforcement action disclosed.
AlphAI scores every news story that mentions HRGN with an AI model for sentiment and relevance, and aggregates insider trades from Harvard Apparatus Regenerative Technology, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Berkshire Hathaway bought Lennar (LEN) shares worth $136M. Insiders at Anixa (ANIX), DeFi (DFDV), Clipper (CLPR), and Harvard Apparatus (HRGN) made purchases. CrowdStrike (CRWD) CFO and Robinhood (HOOD) CEO sold shares worth $125M and $30M, respectively. Everpure (P) and Fastly (FSLY) insiders also sold shares.
2 min readHe Junli (CEO) purchased 368,630 shares of Harvard Apparatus Regenerative Technology, Inc. (HRGN) at an average of $1.07 ($1.05–$2.15, $0.39M total) across 2 trades over 2026-09-11 to 2026-09-15.
1 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry Into a Material Definitive Agreement. On September 11, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into Securities Purchase Agreements (each a “Purchase Agreement”) with certain investors (the “Investors”) pursuant to which the I
2 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01. Entry into a Material Definitive Agreement. May 2026 Bridge Note On May 8, 2026, Harvard Apparatus Regenerative Technology, Inc. (the “Company”) entered into a loan arrangement with Junli He, the Chairman and Chief Executive Officer of the Company (the “Lender”), pursu
2 min readHarvard Apparatus Regenerative Technology, Inc. (HRGN) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. hrgn20260623_8k.htm false 0001563665 0001563665 2026-06-18 2026-06-18 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event repo
3 min read